Teratogenic drug screening. Present procedures and requirements.
D000014:Abnormalities, Drug-Induced; D000015:Abnormalities, Multiple; D000818:Animals; D000830:Animals, Laboratory; D001379:Azathioprine / Q000494:pharmacology; D002415:Cats; D004195:Disease Models, Animal; D004285:Dogs; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005298:Fertility / Q000187:drug effects; D005333:Fetus / Q000187:drug effects; D006801:Humans; D008297:Male; D051379:Mice; D004364:Pharmaceutical Preparations / Q000592:standards*; D011247:Pregnancy; D011323:Primates; D011817:Rabbits; D051381:Rats; D012098:Reproduction / Q000187:drug effects; D013045:Species Specificity; D013552:Swine; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations; D001379:Azathioprine